Viz.ai connects clinical AI findings with the teams responsible for follow-up

Viz.ai builds an AI-powered care coordination platform that connects suspected findings in clinical data with the professionals responsible for assessing them. Viz.ai One brings specialty applications and communication together, while Viz Assist adds generative workflow support. The central distinction is between detecting a signal, notifying a team and completing appropriate clinical evaluation; those are separate events.

01 / ProductThe platform joins specialist algorithms with communication

Viz.ai One combines clinical applications with communication across mobile, desktop and radiology workflows. Its named suites span areas including neurology, cardiology, vascular medicine, trauma and radiology. The platform is intended to help information reach the relevant team, including across referring and treating centers. That coordination role is as important to understanding the company as the underlying algorithms.

The Viz LVO product provides a concrete example: an imaging signal can prompt a specialist to review a suspected large vessel occlusion. The indications for use define LVO as a notification-only tool operating in parallel with standard care. Its output does not make or confirm a diagnosis, and compressed mobile previews are informational rather than diagnostic images.

Viz Assist is a related but different product layer. The company describes generative AI for chart summarization, documentation support and guideline-related assistance within its platform. Those capabilities should not inherit the regulatory status or performance evidence of a separate imaging application. Buyers need to identify exactly which feature is being proposed and the role it plays.

The company overview describes a broad portfolio of AI algorithms and clinical data types. That establishes meaningful AI relevance, but portfolio size is not a useful substitute for a deployment specification. A hospital’s immediate decision concerns the particular application, patient population, data feed and receiving service it intends to use.

02 / AudienceCare networks need an accountable receiving team

Viz.ai is relevant to hospitals and connected care networks where delays arise between a finding and specialist attention. A technically accurate notification can still fail operationally if the wrong person receives it, the on-call roster is stale or the recipient cannot access the diagnostic record. The evaluation therefore needs clinical, operational and technology participants together.

The company also offers a life sciences route aimed at care pathways and identifying patients who may need further evaluation. This is a distinct organizational context from a hospital’s acute imaging workflow. A prospective partner should specify the allowed purpose, the participating providers and the boundaries of any patient identification process rather than assuming that the same data access applies everywhere.

Tempus is an adjacent comparison for combining clinical data and AI in precision medicine. Abridge focuses on encounter documentation. Viz.ai’s characteristic reader question is how an identified signal reaches a care team and becomes an appropriately reviewed next step. These companies can occupy different positions in the same health system rather than competing for an identical task.

03 / WorkflowA proposed alert pilot should follow the signal through the handoff

For a proposed hospital evaluation, choose a single application and agree its intended use with the responsible clinical service. Use an approved retrospective or test dataset under the institution’s governance process. Record which studies should be eligible for analysis and which should be excluded. The first question is whether the application receives the expected data, not whether its interface looks convincing.

Follow one eligible study through processing, notification and review. Inspect the timestamps and the identity of the notified team. Then verify that the professional can reach the appropriate diagnostic viewer and patient context. For a notification-only application, that subsequent review is a distinct necessary step, not an optional embellishment to an AI result.

Include a case where the usual specialist is unavailable. Examine the on-call routing, acknowledgement and escalation process. A notification delivered to a device does not prove that an accountable person has accepted responsibility. The pilot should establish what the organization can see about unanswered alerts and how staff recover when the expected handoff fails.

Test a duplicate study or repeated transfer between systems. The same clinical event can appear more than once in a network. Review whether the team can recognize that relationship and avoid unnecessary repeated work. This is an operational test proposal, not a claim about a known Viz.ai defect or a report of a live patient experiment.

For Viz Assist, run a separate evaluation using approved synthetic chart information. Compare the summary with its source record, including an amended note and conflicting dates. Ask the reviewer to identify which information is missing and which statements require correction. Do not combine this task’s results with an imaging application’s detection metrics under a single accuracy label.

Finally, evaluate workflow outcomes and model behavior separately. Time to notification, time to acknowledgement and time to the intended professional review describe different intervals. A faster first interval may be useful without improving the last one. Sequenced has not tested these clinical systems; this proposed method is intended to help a buying team establish the evidence relevant to its own service.

04 / PricingEnterprise access requires application-specific scope

The public contact page offers an organizational sales route. The reviewed pages do not establish a standard public subscription tariff for Viz.ai One or Viz Assist. A hospital should request a proposal identifying the applications, sites and services included. An invitation to request a demo is not confirmation that every suite or feature is available under one contract.

The commercial scope should distinguish platform access, selected clinical applications, integration work and ongoing support. Ask how a new site or a new application would change the agreement. Those are questions for the written proposal rather than claims that each item carries a separate charge. A broad portfolio can simplify procurement only if the actual entitlements and responsibilities are clear.

Evaluate cost against the operational problem the organization intends to solve. If the objective is more reliable specialist notification, include the receiving team’s effort and unresolved alerts. If the objective is documentation support, assess review time and correction burden separately. Vendor case studies provide context for discussion but do not establish a guaranteed return or a transferable clinical outcome.

05 / DistinctionsCoordination makes the algorithm part of a service

The substantive distinction is the relationship between specialty AI and the care network around it. An algorithm can identify a suspected finding without knowing whether the next team is available or whether a transfer has completed. A coordination platform gives the buyer a way to examine those surrounding steps as a connected workflow.

The One platform description emphasizes cross-device access, communication and connections to EHR and PACS systems. These capabilities matter because a specialist may encounter the alert away from a diagnostic workstation. The interface can accelerate awareness, while the diagnostic environment remains necessary for the relevant clinical assessment.

Adding generative assistance creates further opportunities and further evaluation tasks. A chart summary can prepare someone for review, but its usefulness depends on source completeness and the distinction between recorded facts and generated interpretation. The right comparison is not whether an AI can produce a plausible paragraph. It is whether the responsible professional can use the output efficiently and inspect what supports it.

06 / QuestionsIntended use must stay attached to the individual product

The most consequential boundary is product-specific. The published LVO instructions require diagnostic image review and patient evaluation rather than reliance on the mobile notification. Other applications have their own intended uses. Buyers should obtain the current documentation for the exact software version and geography instead of applying one product’s clearance to the entire portfolio.

What happens when processing or communication fails? The health system needs to distinguish an eligible study that produced no suspected finding from a study that was never successfully analyzed. Similarly, a sent alert, a delivered alert and a completed review should remain separate states. Otherwise a dashboard can imply clinical coverage that the underlying process has not established.

Which Viz Assist features are in the proposed deployment? The product page describes several forms of assistance, but it does not establish that every feature is generally available in every customer environment. Confirm enabled capabilities, approved sources and review requirements before using them to plan staffing or patient-facing workflows.

07 / DecisionChoose a pathway whose handoffs can be observed

Viz.ai is a strong candidate for organizations evaluating AI-supported detection alongside care coordination. Begin with a specific pathway, verify the application’s intended use and follow the result through human review. The value case should reflect the complete service, including alerts that remain unanswered and studies that cannot be processed.

A broader rollout becomes more defensible when the organization can show that the system improves awareness and coordination while preserving professional responsibility. Keep generative assistance, imaging performance and operational outcomes as distinct evidence categories. That makes it possible to expand the product for a clear reason and to recognize when a process problem needs attention outside the software.